Sign In
Buy THTX
$3.39
+0 (+0%)
At Close: Dec 24, 2025
MONTREAL, May 25, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and co
Theratechnologies to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
07:30am, Tuesday, 18'th Apr 2023
Montreal, Quebec--(Newsfile Corp. - April 18, 2023) - Theratechnologies (NASDAQ: THTX) (TSX: TH), a biopharmaceutical company focused on the development and commercialization of innovative therapies,
Theratechnologies stock price continues higher on company guidance
02:33pm, Friday, 14'th Apr 2023
Theratechnologies (TSX:TH) Inc shares continued to advance Friday, up 12% to $1.29 following a 10% gain on Thursday, after the biopharmaceutical company announced that it expects its fiscal year 2023
Theratechnologies Inc. (THTX) Q1 2023 Earnings Call Transcript
11:51am, Wednesday, 12'th Apr 2023
Theratechnologies Inc. (NASDAQ:THTX ) Q1 2023 Earnings Conference Call April 12, 2023 8:30 AM ET Company Participants Elif McDonald - Head of Investor Relations Paul Levesque - President and Chief Exe
Theratechnologies shares up as first quarter revenues rise
10:47am, Wednesday, 12'th Apr 2023
Theratechnologies (TSX:TH) has reported first-quarter financial results with consolidated revenue growing by 7% to US$19.9mln. The Montreal-headquartered biopharmaceutical firm told investors that the
Theratechnologies to Announce First Quarter 2023 Financial Results and Provide Business Update
07:30am, Monday, 03'rd Apr 2023
MONTREAL, April 03, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a biopharmaceutical company focused on the development and commercialization of
MONTREAL, March 14, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update
05:00pm, Tuesday, 14'th Feb 2023
MONTREAL, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a biopharmaceutical company focused on the development and commercialization of i
Theratechnologies Inc. (THTX) Q3 2022 Earnings Call Transcript
11:38am, Thursday, 13'th Oct 2022
Theratechnologies Inc. (NASDAQ:THTX ) Q3 2022 Earnings Conference Call October 13, 2022 8:30 AM ET Company Participants Elif McDonald - Head of Investor Relations Paul Levesque - President and Chief E
Theratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update
07:30am, Monday, 26'th Sep 2022
MONTREAL, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innova
Theratechnologies to Present at the Cantor Oncology, Hematology & HemeOnc Conference
04:15pm, Monday, 19'th Sep 2022
MONTREAL, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and
Theratechnologies to Present at the Canaccord Genuity 42nd Annual Growth Conference
07:30am, Tuesday, 02'nd Aug 2022
MONTREAL, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and c
Theratechnologies Inc. (THTX) CEO Paul Levesque on Q2 2022 Results - Earnings Call Transcript
01:42pm, Thursday, 14'th Jul 2022
Theratechnologies Inc. (NASDAQ:THTX ) Q2 2022 Earnings Conference Call July 14, 2021 8:30 AM ET Company Participants Elif McDonald - Senior Director, Investor Relations Paul Levesque - President & CEO
Theratechnologies Stock Jumps After Q2 Earnings, FY22 Guidance
12:15pm, Thursday, 14'th Jul 2022
Theratechnologies Inc (NASDAQ: THTX) issued an update on the dose escalation portion of the TH1902 Phase 1 safety study. 18 heavily pretreated patients were enrolled.
Theratechnologies to Present at Bloom Burton & Co. Healthcare Investor Conference 2022
04:16pm, Monday, 25'th Apr 2022
Presentation time starts on Tuesday, May 3rd at 1:30PM ET Presentation time starts on Tuesday, May 3rd at 1:30PM ET
